ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Named VP, Health sciences At UNM

February 11, 1994

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

Cooperative Groups Fight to Keep CGOP Alive As DCPC, DCT Argue Over Who Pays

July 11, 1986